Prosight Management, LP Stealth Bio Therapeutics Corp Transaction History

Prosight Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$1.27 - $1.62 $325,175 - $414,791	-256,044 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$1.32 - $2.23 $46,332 - $78,273	-35,100 Reduced 12.06%	256,044 $346,000
Q2 2020 Aug 14, 2020	SELL	$1.23 - $2.22 $55,378 - $99,951	-45,023 Reduced 13.39%	291,144 $533,000
Q1 2020 May 15, 2020	BUY	$0.97 - $3.13 $326,081 - $1.05 Million	336,167 New	336,167 $417,000

2.94K

Ticker MITO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,548,600
Description
Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duche...

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

Stay updated on Prosight Management, LP with notifications on news.